116 related articles for article (PubMed ID: 25131790)
21. [Determination of serum semicarbazide-sensitive amine oxidase activity in diabetic retinopathy in type-2 diabetes].
Dura E; Mészáros Z; Salacz G; Magyar K; Romics L; Karádi I
Orv Hetil; 2002 Nov; 143(47):2637-44. PubMed ID: 12532650
[TBL] [Abstract][Full Text] [Related]
22. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
Majithiya JB; Paramar AN; Balaraman R
Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
[TBL] [Abstract][Full Text] [Related]
23. Sitagliptin inhibits endothelin-1 expression in the aortic endothelium of rats with streptozotocin-induced diabetes by suppressing the nuclear factor-κB/IκBα system through the activation of AMP-activated protein kinase.
Tang ST; Su H; Zhang Q; Tang HQ; Wang CJ; Zhou Q; Wei W; Zhu HQ; Wang Y
Int J Mol Med; 2016 Jun; 37(6):1558-66. PubMed ID: 27122056
[TBL] [Abstract][Full Text] [Related]
24. Gliquidone versus metformin: differential effects on aorta in streptozotocin induced diabetic rats.
Tan Z; Xu Z; Gui Q; Wu W; Yang Y
Chin Med J (Engl); 2014; 127(7):1298-303. PubMed ID: 24709184
[TBL] [Abstract][Full Text] [Related]
25. The role of plasma semicarbazide-sensitive amine oxidase in allylamine and beta-aminopropionitrile cardiovascular toxicity: mechanisms of myocardial protection and aortic medial injury in rats.
Conklin DJ; Trent MB; Boor PJ
Toxicology; 1999 Nov; 138(3):137-54. PubMed ID: 10593505
[TBL] [Abstract][Full Text] [Related]
26. [Aortic endothelium-dependent vasodilation function and PI3K-, PKB-, eNOS mRNA expressions in insulin-resistant and type 2 diabetic rats].
Wu J; Lei MX; Liu L; Xie XY
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Mar; 35(3):265-70. PubMed ID: 17582297
[TBL] [Abstract][Full Text] [Related]
27. Semicarbazide-sensitive amine oxidase in transgenic mice with diabetes.
Gokturk C; Nordquist J; Sugimoto H; Forsberg-Nilsson K; Nilsson J; Oreland L
Biochem Biophys Res Commun; 2004 Dec; 325(3):1013-20. PubMed ID: 15541390
[TBL] [Abstract][Full Text] [Related]
28. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase.
Langford SD; Trent MB; Balakumaran A; Boor PJ
Toxicol Appl Pharmacol; 1999 Mar; 155(3):237-44. PubMed ID: 10079209
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of glucose transport by semicarbazide-sensitive amine oxidase activity in adipocytes from diabetic rats.
Abella A; Marti L; Carpéné C; Palacín M; Testar X; Zorzano A
J Physiol Biochem; 2003 Sep; 59(3):153-60. PubMed ID: 15000445
[TBL] [Abstract][Full Text] [Related]
30. Inhibitor sensitivity of human serum and vascular semicarbazide-sensitive amine oxidases.
Mészáros Z; Csányi A; Vallus G; Szombathy T; Karádi I; Magyar K
Neurobiology (Bp); 2000; 8(2):215-23. PubMed ID: 11061216
[TBL] [Abstract][Full Text] [Related]
31. Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review.
Obata T
Life Sci; 2006 Jun; 79(5):417-22. PubMed ID: 16487546
[TBL] [Abstract][Full Text] [Related]
32. Semicarbazide-sensitive amine oxidase substrates potentiate hydralazine hypotension: possible role of hydrogen peroxide.
Vidrio H; Medina M; González-Romo P; Lorenzana-Jiménez M; Díaz-Arista P; Baeza A
J Pharmacol Exp Ther; 2003 Nov; 307(2):497-504. PubMed ID: 12970383
[TBL] [Abstract][Full Text] [Related]
33. Prolonged treatment with aminoguanidine strongly inhibits adipocyte semicarbazide-sensitive amine oxidase and slightly reduces fat deposition in obese Zucker rats.
Prévot D; Soltesz Z; Abello V; Wanecq E; Valet P; Unzeta M; Carpéné C
Pharmacol Res; 2007 Jul; 56(1):70-9. PubMed ID: 17548204
[TBL] [Abstract][Full Text] [Related]
34. Semicarbazide-sensitive amine oxidase (SSAO) gene expression in alloxan-induced diabetes in mice.
Nordquist JE; Göktürk C; Oreland L
Mol Med; 2002 Dec; 8(12):824-9. PubMed ID: 12606817
[TBL] [Abstract][Full Text] [Related]
35. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications.
Yu PH; Zuo DM
Diabetologia; 1997 Nov; 40(11):1243-50. PubMed ID: 9389414
[TBL] [Abstract][Full Text] [Related]
36. [The protective effect of nourishing yin and promoting blood flow recipe on the aortic endothelium injury of diabetic rats].
Li B; Qi JS; Cao D
Zhong Yao Cai; 2009 Aug; 32(8):1245-8. PubMed ID: 19960948
[TBL] [Abstract][Full Text] [Related]
37. Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.
Carpéné C; Abello V; Iffiú-Soltész Z; Mercier N; Fève B; Valet P
Pharmacol Res; 2008 Jun; 57(6):426-34. PubMed ID: 18539478
[TBL] [Abstract][Full Text] [Related]
38. Modifications of arterial phenotype in response to amine oxidase inhibition by semicarbazide.
Mercier N; El Hadri K; Osborne-Pellegrin M; Nehme J; Perret C; Labat C; Regnault V; Lamazière JM; Challande P; Lacolley P; Fève B
Hypertension; 2007 Jul; 50(1):234-41. PubMed ID: 17452500
[TBL] [Abstract][Full Text] [Related]
39. Δ9-tetrahydrocannabinol treatment improved endothelium-dependent relaxation on streptozotocin/nicotinamide-induced diabetic rat aorta.
Altınok A; Coşkun ZM; Karaoğlu K; Bolkent S; Akkan AG; Özyazgan S
Acta Physiol Hung; 2015 Mar; 102(1):51-9. PubMed ID: 25804389
[TBL] [Abstract][Full Text] [Related]
40. Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy.
Garpenstrand H; Ekblom J; Bäcklund LB; Oreland L; Rosenqvist U
Diabet Med; 1999 Jun; 16(6):514-21. PubMed ID: 10391401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
